Cell cycle arrest and inhibition of the survival, proliferation, and migration of PC3 cells expressing CD44 and CD133 isolated from prostate cancer by inhibiting p‐p38, p‐ERK, NF‐κB, and PARP.200. Here, CD44 is linked to prostate carcinoma.